Overview

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
0
Participant gender:
All
Summary
Local anesthetic resistance is commonly reported by patients with EDS. However, there are no objective data on the occurrence of local anesthetic resistance in EDS patients and in healthy volunteers. The investigators propose to collect such objective data on the frequency of drug resistance and whether any problems with local anesthesia are due to initial ineffectiveness or due to its effects dissipating too soon.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Calgary
Collaborator:
Vanderbilt University Medical Center
Treatments:
Bupivacaine
Lidocaine
Criteria
Inclusion Criteria:

- EDS patients, clinically diagnosed hypermobile EDS based on 2017 criteria

- EDS patients with genetically proven non-hypermobile EDS

- Healthy participants, no EDS

- Able and willing to provide informed consent

Exclusion Criteria:

- Known allergy to Lidocaine or Bupivacaine

- Unable to provide informed consent